The Rapamycin Longevity Lab is a cutting-edge research organization focused on advancing the use of mTOR inhibitors as the core component in longevity combinational therapies. The lab is founded by Krister Kauppi and the aim is to develop combinational therapies that not only slow down aging but also eventually solve aging altogether. By leveraging mTOR inhibitor’s potential and combining it with other interventions, the lab seeks to extend lifespan and improve healthspan in both animal models and humans.